Sebastian Siol is looking for new materials with unusual properties that were so far not accessible in experiments. To do this, he connects partners who don't really fit together: One partner forces the other into a state that would not be possible without the unlikely pairing. Siol also makes sure that the crystal bonds last in everyday life. Only then are they interesting for industrial applications.
New University of Nottingham research proves that advanced materials containing molecules that switch states in response to environmental stimuli such as light can be fabricated using 3D printing. The study findings have the potential to vastly increase the functional capabilities of 3D-printed devices for industries such as electronics, healthcare and quantum computing.
Monash researchers have developed a computer program which has revealed a previously unknown combination of drugs that may be the answer to Triple Negative Breast Cancer (TNBC), using genetic and treatment data from TNBC cells grown in labs and from hundreds of patients world-wide. Importantly researchers can tell, by inputting patients' genomic and proteomic information into their computer model, who may benefit from this drug combination or not -- saving precious time.
UBC researchers have developed a type of 'smart stent' that monitors even subtle changes in the flow of blood through the artery, detecting the narrowing in its earliest stages and making early diagnosis and treatment possible.
A treatment that infuses a conventional neoprene wetsuit with a heavy inert gas can improve a diver's survival time in frigid waters by a factor of three, according to scientists and others.
As a key global enabler of the revolutionary genome editing technology known as CRISPR, the nonprofit organization Addgene has made available more than 100,000 CRISPR plasmids (circular DNA fragments) to 3,400 laboratories worldwide.
Researchers have developed a technique that takes advantage of gold nanoparticles to trigger the sequential unfolding of three-dimensional structures using different wavelengths of light.
Researchers at the RIKEN Center for Sustainable Resource Science (CSRS) have discovered a process through which gene expression in plants is regulated by light. Published in Proceedings of the National Academy of Sciences USA, the study found that blue light triggers a shift in which portion of a gene is ultimately expressed.
EPFL and US scientists have developed a computational method that can design synthetic cell receptors that can be used to isolate how drugs work in a cell, minimize or even altogether prevent side effects and redirect their action.
Scientists report finding a potentially promising treatment target for aggressive and deadly high-grade brain cancers like glioblastoma. Publishing online June 18 in Nature Cell Biology, the study also reports the current lack of a drug that hits the molecular target keeps it from being advanced for testing as a therapeutic strategy for patients with few treatment options. The researchers point to a protein that helps regulate cell metabolism called AMPK (AMP-activated protein kinase).